2019-nCov_pcDNA3.1(+)-P2A-eGFP plasmid from Haisheng Yu
Ordering:
| Name | Cat. No. | Availability | Price | |
|---|---|---|---|---|
| 2019-nCov_pcDNA3.1(+)-P2A-eGFP | MC_0101087 |
4 µg of lyophilized plasmid (1 µg for low-copy plasmid) |
$65 | Edit in GenSmart Design |
This material may be covered by one or more patents, trademarks and/or copy rights owned or controlled by Depositors or any third parties. This material is available to academic and nonprofit organizations for research use only. Please contact MolecularCloud at plasmid@genscript.com and the Depositor directly if you are from industrial institute or attempt for profit application. This material is not intended to be used therapeutic or diagnostic purposed in humans or animals.
| Keywords | Expression |
| Vector Backbone | pcDNA3.1(+)-P2A-eGFP |
| Source | |
| Depositor | Haisheng Yu |
| Organization | |
| Description | The plasmid is used for 2019-nCoV(SARS-CoV-2) surface glycoprotein expression (Codon Optimized for Mouse expression system). The surface glycoprotein is integrated with eGFP protein through P2A, which can be used for flow cytometry antibody screening or immunological research. |
| Publication |
| Plasmid Copy | High Copy |
| Bacterial Resistance | Ampicillin |
| Growth Strain | TOP10 |
| Growth Temperature | 37°C |
| Plasmid Size (bp) | 9961 |
